Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Welch

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
American Journal of Clinical Pathology|March 1, 1997
The utility of patient age in evaluating prostate cancerH T Poteat, G T Ho, M L Lee, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
Gynecologic Oncology|June 1, 2000
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumorsL W Huang, A P Garrett, D A Bell, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1989
Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 casesA G Montag, E L Jenison, C T Griffiths, et al.
Obstetrics and Gynecology|November 1, 1982
Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinomaS J Robboy, W R Welch, R H Young, et al.
Cancer|August 15, 1994
Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolismD W Cramer, M G Muto, J K Reichardt, et al.
Oncogene|May 16, 1996
Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumorsI Wertheim, J Tangir, M G Muto, et al.
Oncogene|February 2, 1999
Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumorsT D Iyengar, S Ng, C C Lau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2007
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasionE C Koon, P C Ma, R Salgia, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
American Journal of Clinical Pathology|March 1, 1997
The utility of patient age in evaluating prostate cancerH T Poteat, G T Ho, M L Lee, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
Gynecologic Oncology|June 1, 2000
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumorsL W Huang, A P Garrett, D A Bell, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1989
Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 casesA G Montag, E L Jenison, C T Griffiths, et al.
Obstetrics and Gynecology|November 1, 1982
Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinomaS J Robboy, W R Welch, R H Young, et al.
Cancer|August 15, 1994
Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolismD W Cramer, M G Muto, J K Reichardt, et al.
Oncogene|May 16, 1996
Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumorsI Wertheim, J Tangir, M G Muto, et al.
Oncogene|February 2, 1999
Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumorsT D Iyengar, S Ng, C C Lau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2007
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasionE C Koon, P C Ma, R Salgia, et al.
Pageof 10